Type to search

Appointments Industry News News

Azenta Life Sciences Names Matthew McManus Chief Operating Officer

Azenta Life Sciences Names Matthew McManus Chief Operating Officer | Pharmtech Focus

Azenta, Inc. (Nasdaq: AZTA) today announced that it has appointed Matthew McManus Chief Operating Officer effective January 17th.  In this newly created role, Dr. McManus will oversee Life Sciences Products, Services, and all commercial operations of the business and will report directly to the CEO.

“We are excited to have Matt join the Company as our COO,” said Steve Schwartz, President and CEO of Azenta. “Matt brings decades of expertise in life sciences. His depth of knowledge and valuable perspective will enhance our leadership position in the markets we serve.”

Dr. McManus joins Azenta with over 25 years of experience in the life sciences industry and was most recently Senior Vice President and General Manager of the Molecular Diagnostics Division at Bio-Techne following its acquisition of Asuragen, where Dr. McManus was President and CEO.  Dr. McManus was previously the President and CEO of PrimeraDx.  He received his M.D. and Ph.D. from the University of Pennsylvania School of Medicine, his MBA from Boston College and his B.A. in Economics from College of the Holy Cross.


People in this post:

Companies in this post:

Next Up